Brief: Standard BioTools Reports Qtrly Loss Per Share $0.82

Standard BioTools

08/08/2022 23:17

Aug 8 (Reuters) - Standard BioTools Inc  LAB.O :
    * STANDARD BIOTOOLS ANNOUNCES SECOND QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES STRATEGIC UPDATE
    * Q2 REVENUE $18.8 MILLION
    * STANDARD BIOTOOLS - CASH, CASH EQUIVALENTS, SHORT-TERM
INVESTMENTS EXPECTED TO PROVIDE SUFFICIENT RUNWAY TO GENERATE
POSITIVE FREE CASH FLOW BY END OF 2024
    * QTRLY LOSS PER SHARE $0.82

Source text for Eikon:  ID:nGNX2LLXW7 
Further company coverage:  LAB.O 

 ((Reuters.Briefs@thomsonreuters.com;))